Evaluating Kidney Damage with CD10 Staining
Author Information
Author(s): Tagboto S, Griffiths A Paul
Primary Institution: Department of Nephrology, University Hospital of North Staffordshire
Hypothesis
Can CD10 monoclonal antibody staining and biochemical assessments effectively quantify renal ischaemic damage?
Conclusion
The study suggests that CD10 monoclonal antibody staining and biochemical tests can aid in diagnosing and assessing ischaemic renal damage.
Supporting Evidence
- CD10 antibody staining correlated well with traditional PAS staining.
- Biochemical assays demonstrated the efficacy of Soltran in preserving renal tissue.
- Higher immunostaining scores correlated positively with higher histology scores.
Takeaway
This study looked at how well a special stain and a chemical test can show if kidney tissue is damaged. It found that these methods can help doctors understand kidney problems better.
Methodology
Rabbit kidney tissue was subjected to warm or cold ischaemia for 20 hours, followed by staining and biochemical viability assessments.
Limitations
The study used a laboratory model, which may not fully replicate human kidney responses.
Participant Demographics
Kidney tissues were obtained from laboratory rabbits.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website